MA52793A - Agent antitumoral et méthode de traitement d'une tumeur - Google Patents

Agent antitumoral et méthode de traitement d'une tumeur

Info

Publication number
MA52793A
MA52793A MA052793A MA52793A MA52793A MA 52793 A MA52793 A MA 52793A MA 052793 A MA052793 A MA 052793A MA 52793 A MA52793 A MA 52793A MA 52793 A MA52793 A MA 52793A
Authority
MA
Morocco
Prior art keywords
tumor
treatment method
agent
tumor treatment
tumor agent
Prior art date
Application number
MA052793A
Other languages
English (en)
Inventor
Hiroshi Hirai
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA52793A publication Critical patent/MA52793A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA052793A 2018-05-29 2019-05-28 Agent antitumoral et méthode de traitement d'une tumeur MA52793A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862677379P 2018-05-29 2018-05-29

Publications (1)

Publication Number Publication Date
MA52793A true MA52793A (fr) 2021-04-14

Family

ID=68698132

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052793A MA52793A (fr) 2018-05-29 2019-05-28 Agent antitumoral et méthode de traitement d'une tumeur

Country Status (6)

Country Link
US (1) US12036215B2 (fr)
EP (1) EP3804721A4 (fr)
JP (1) JP7227968B2 (fr)
MA (1) MA52793A (fr)
TW (1) TWI813694B (fr)
WO (1) WO2019230679A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485146B (zh) 2012-02-29 2015-05-21 Taiho Pharmaceutical Co Ltd Novel piperidine compounds or salts thereof
US9012475B2 (en) * 2013-08-27 2015-04-21 Taiho Pharmaceutical Co., Ltd. Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor
TWI693218B (zh) 2014-11-14 2020-05-11 美商美國禮來大藥廠 極光ａ激酶抑制劑
MA47129A (fr) 2016-12-22 2019-10-30 Taiho Pharmaceutical Co Ltd Sel de composé pipéridine substitué

Also Published As

Publication number Publication date
EP3804721A1 (fr) 2021-04-14
JPWO2019230679A1 (ja) 2021-05-20
US12036215B2 (en) 2024-07-16
EP3804721A4 (fr) 2022-03-16
WO2019230679A1 (fr) 2019-12-05
TWI813694B (zh) 2023-09-01
TW202015680A (zh) 2020-05-01
US20210236475A1 (en) 2021-08-05
JP7227968B2 (ja) 2023-02-22

Similar Documents

Publication Publication Date Title
IL280707A (en) Diagnostic and therapeutic methods for the treatment of breast cancer
EP3506944A4 (fr) Compositions et méthodes de traitement d'un cancer déficient en suppresseurs tumoraux
EP3452166A4 (fr) Stimulation intranasale pour le traitement de la maladie de la glande de meibomius et de la blépharite
MX2020001774A (es) Composiciones y métodos para tratar enfermedad colestásica.
EP3778649A4 (fr) Méthode et composition de traitement de tumeurs
EP3983445A4 (fr) Compositions et méthodes de traitement du cancer
EP3998239A4 (fr) Ensemble électrolytique et appareil de traitement de vêtements
EP3423100A4 (fr) Compositions destinées à traiter l'inflammation et méthodes de traitement associées
EP3833340A4 (fr) Compositions et procédés de traitement de la presbytie
IL280348A (en) Surface treatment compositions and methods
EP3781584A4 (fr) Promédicaments de 4'-thio-nucléotide et de nucléoside pour le traitement du cancer
EP3681508A4 (fr) Méthode et composition pour le traitement d'une infection virale
EP3883553A4 (fr) Composés aryl-aniline et hétéroaryl-aniline pour le traitement de cancers de la peau
EP3775171A4 (fr) Procédés de traitement d'un cancer résiduel minimal
EP3723733A4 (fr) Méthodes et compositions pour le traitement du cancer utilisant des exosomes associés à l'édition génique
EP3697767A4 (fr) Composés et procédés de traitement du cancer
PL3952858T3 (pl) Sposób leczenia guzów
EP3679123A4 (fr) Bactéries pour le ciblage de tumeurs et le traitement du cancer
IL289251A (en) Methods and compositions for treatment of pancreatic cancer
EP3731853A4 (fr) Procédé de traitement du cancer du sein et de maladies chroniques
EP3672619A4 (fr) Matériels et méthodes d'évaluation et de traitement du cancer
IL282948A (en) Compositions and methods for treating cancer
EP4055153A4 (fr) Traitement de cancer primaire et métastatique
EP3987032A4 (fr) Méthodes et compositions permettant le traitement du cancer
MA52793A (fr) Agent antitumoral et méthode de traitement d'une tumeur